BG49827A3 - Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор - Google Patents

Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор

Info

Publication number
BG49827A3
BG49827A3 BG086469A BG8646988A BG49827A3 BG 49827 A3 BG49827 A3 BG 49827A3 BG 086469 A BG086469 A BG 086469A BG 8646988 A BG8646988 A BG 8646988A BG 49827 A3 BG49827 A3 BG 49827A3
Authority
BG
Bulgaria
Prior art keywords
stimulating factor
colony stimulating
biologically active
recombinant human
active recombinant
Prior art date
Application number
BG086469A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Halenbeck
Cynthia Cowgill
Kirston Koths
Walter Laird
Original Assignee
Chiron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corporation filed Critical Chiron Corporation
Publication of BG49827A3 publication Critical patent/BG49827A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG086469A 1987-04-16 1988-12-16 Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор BG49827A3 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4017487A 1987-04-16 1987-04-16
US11400187A 1987-10-27 1987-10-27
PCT/US1988/001189 WO1988008003A1 (en) 1987-04-16 1988-04-18 Production of purified, biologically active, bacterially produced recombinant human csf-1

Publications (1)

Publication Number Publication Date
BG49827A3 true BG49827A3 (bg) 1992-02-14

Family

ID=26716797

Family Applications (1)

Application Number Title Priority Date Filing Date
BG086469A BG49827A3 (bg) 1987-04-16 1988-12-16 Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор

Country Status (10)

Country Link
EP (2) EP0818466B1 (de)
JP (1) JP2656964B2 (de)
AT (2) ATE167192T1 (de)
AU (1) AU610182B2 (de)
BG (1) BG49827A3 (de)
DE (2) DE3856203T2 (de)
FI (1) FI96872C (de)
IL (1) IL86090A (de)
NO (1) NO300067B1 (de)
WO (1) WO1988008003A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
WO1989010407A1 (en) * 1988-04-29 1989-11-02 Genetics Institute, Inc. Homogeneous dimeric m-csf and storage stable formulations thereof
EP0410751B1 (de) * 1989-07-27 1996-04-10 Denki Kagaku Kogyo Kabushiki Kaisha Für M-CSF kodierendes Gen und dazu gehörende rekombinante Systeme
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
JPH06500084A (ja) * 1990-08-20 1994-01-06 ノボ　ノルディスク　アクティーゼルスカブ 生物学的に活性な化合物、その製造方法及びその利用
AU664021B2 (en) * 1990-09-05 1995-11-02 Natinco Nv Solubilization of proteins in active forms
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0668914B1 (de) 1992-06-09 2000-08-16 Chiron Corporation Kristallisierung von m-csf
AU661914B2 (en) * 1992-08-18 1995-08-10 Jean-Louis Odore Support structure for a shelter cover
FI951541A0 (fi) * 1993-08-04 1995-03-31 Ciba Geigy Ag Suurimolekyylipainoinen desulfatohirudiini
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
FR2796071B1 (fr) * 1999-07-08 2001-09-07 Hoechst Marion Roussel Inc Procede de purification de facteur de stimulation de colonies de granulocytes
US6808902B1 (en) * 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
DE102004041639A1 (de) * 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
EP3366692A1 (de) 2009-06-22 2018-08-29 Amgen, Inc Proteinneufaltung mit einem chemisch gesteuerten redoxzustand
AU2010266093B2 (en) 2009-06-25 2013-06-27 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
DE202009019091U1 (de) 2009-12-21 2016-05-23 Agilent Technologies, Inc. - A Delaware Corporation - Fittingelement mit frontseitiger Einlage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
DE3689391T2 (de) * 1985-02-05 1994-06-30 Cetus Oncology Corp., Emeryville, Calif. Rekombinanter koloniestimulierender faktor-1.
MX9203130A (es) * 1986-05-06 1992-07-01 Genetics Inst Produccion de m-csf
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer

Also Published As

Publication number Publication date
FI96872C (fi) 1996-09-10
JPH01503440A (ja) 1989-11-22
DE3856581T2 (de) 2006-05-24
FI885807A0 (fi) 1988-12-15
NO885555L (no) 1989-01-11
EP0309569A1 (de) 1989-04-05
JP2656964B2 (ja) 1997-09-24
WO1988008003A1 (en) 1988-10-20
AU610182B2 (en) 1991-05-16
NO885555D0 (no) 1988-12-14
IL86090A (en) 1993-03-15
FI885807L (fi) 1988-12-15
ATE167192T1 (de) 1998-06-15
DE3856203T2 (de) 1998-10-08
NO300067B1 (no) 1997-04-01
EP0818466B1 (de) 2005-08-03
DE3856581D1 (de) 2005-09-29
EP0818466A3 (de) 1998-03-25
EP0309569B1 (de) 1998-06-10
IL86090A0 (en) 1988-09-30
ATE301133T1 (de) 2005-08-15
DE3856203D1 (de) 1998-07-16
FI96872B (fi) 1996-05-31
AU1712488A (en) 1988-11-04
EP0818466A2 (de) 1998-01-14

Similar Documents

Publication Publication Date Title
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
DE69721006D1 (de) Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
DK478786A (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
DE3789859D1 (de) Formen des Koloniestimulierungsfaktors 1.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
FI873106A0 (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
NO922953L (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
FI102293B1 (fi) Ihmisen interleukiini-3:n molekulaarinen kloonaus ja ilmentäminen
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
BR9007115A (pt) Novo trombolitico
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
SE8505920D0 (sv) New protein and its use
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
IT1198233B (it) Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.